The effect of cyclosporine-A on labeling blood cells with radiopharmaceuticals

Nuclear Medicine and Biology

Volumn 23, Issue 8, 1996, Pages 1019-1021

  Owunwanne, A ^a   Shihab Eldeen, A ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b NONE

Author keywords

111In oxine leukocytes; 111In oxine platelets; 99mTc RBCs; cyclosporine A

Indexed keywords

CYCLOSPORIN A; INDIUM 111; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ISOTOPE LABELING; LEUKOCYTE; RAT; THROMBOCYTE;

ANIMALS; BLOOD CELLS; BLOOD PLATELETS; CYCLOSPORINE; DRUG INTERACTIONS; ERYTHROCYTES; INDIUM RADIOISOTOPES; LEUKOCYTES; ORGANOMETALLIC COMPOUNDS; OXYQUINOLINE; RADIOPHARMACEUTICALS; RATS; TECHNETIUM COMPOUNDS;

EID: 0030292972     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(96)00158-8     Document Type: Article

References (26)

1. 1. Allen M. L., McPherson A. L., Mertes B. J., Preston D. F. and Robinson R. G. (1990) Effects of cyclosporine in lowering red blood cell technetium-99m labelling efficiency. J. Nucl. Med. Technol. 18, 191-193.
2. 2. Backman L., Brandt I., Ringden O. and Dallner G. (1987) Distribution of H3-cyclosporine A in mice by autoradiography. Transplant Proc. 19, 1236-1239.
3. 3. Ballinger J. R., Gerson B., Gulenchyn K. Y., Ruddy T. D. and Davies R. A. (1988) Technetium-99m red blood cell labeling in patients treated with doxorubicin. Clin. Nucl. Med. 13, 169-170.
4. 4. Borel J. F. (1981) The history of cyclosporin-A and its significance. In: Cyclosporin A (Edited by White D.J.G.), pp. 5-17. Elsevier Biomed. Press, Oxford.
5. 5. Datz F.L. (1987) Physiologic imaging of radiolabeled leukocytes. Am. J. Physiology Imag. 2, 196-207.
6. 6. Dewanjee M. K. (1974) Binding of Tc-99m to hemoglobin. J. Nucl. Med. 15, 703-706.
7. 7. Drosos A. A., Skopouli F. N., Galanopoulou V. K., Kitridou R. C. and Moutsopoulos H. M. (1986) Cyclosporine therapy in patients with primary sjogren's syndrome. Results at one year. Scan. J. Rheumatol. 61, 246-249.
8. 8. Foxwell B. M., Frazer G., Winters M., Hiestand P., Wenger R. and Ryffel B. (1988) Identification of cyclosphilin as the erythrocyte cyclosporin-binding protein. Biochem. Biophys. Acta. 938, 445-447.
9. 9. Gleue A. D., Spicer J. A. and Preston D. F. (1995) The effect of cyclosporine on technetium-99m red blood cell labeling using the Ultratag(R) RBC in vitro kit. J. Nucl. Med. Technol. 23, 22-25.
10. 10. Hegge F. N., Hamilton G. W., Larson S. M., Ritchie J. L. and Richards P. (1978) Cardiac chamber imaging: A comparison of red blood cells labelled with Tc-99m in vitro and in vivo. J. Nucl. Med. 19, 129-134.
11. 11. Kahan B. D., Flechner S. M., Lorber M. I., Jensen C., Golden D. and Van Buren C. T. (1986) Complications of cyclosporine therapy. World J. Surg. 10, 348-360.
12. 12. Lee H. -B., Wexler J. P., Scharf S. C. and Blaufox M. D. (1983) Pharmacologic alterations in Tc-99m binding by red blood cells, concise communications. J. Nucl. Med. 24, 397-401.
13. 13. Lemaire M. and Tillement J. P. (1982) Role of lipoproteins and erythrocytes in the in vitro binding and distribution of cyclosporin-A in the blood. J. Pharm. Pharmacol. 34, 715-718.
14. 14. Lensmeyer L. G., Wiebe A. D. and Carlson H. I. (1989) Distribution of cyclosporine-A metabolites among plasma and whole blood: Effect of temperature, hematocrite and metabolite concentration. Clin. Chem. 35(1), 56-63.
15. 15. Niederberger W., Lemaire M., Maurer G., Nussbaumer K. and Wagner O. (1983) Distribution and binding of cyclosporine in blood and tissues. Transplant Proc. 15 (Suppl. 1), 2419-2421.
16. 16. Owunwanne A., Marinsky J. and Blau M. (1977) Change and nature of technetium species produced in the reduction of pertechnetate by stannous ion. J. Nucl. Med. 18, 1099-1105.
17. 17. Ptachcinski R. J., Venkataramanan R. and Burckart G. J. (1986) Clinical pharmacokinetics of cyclosporin. Clin. Pharm. 11, 107-132.
18. 18. Quesniaux V. F. J., Schreier M. H., Wenger M. H., Hiestand P. C., Harding M. W. and van Regenmortel M. H. V. (1987) Cyclophilin binds to the region of cyclosporine involved in its immunosuppresive activity. Eur. J. Immunol. 17, 135-1365.
19. 19. Reichel C., Von Falkenhausen M., Brockmeier D. and Dengler H. J. (1994) Characterization of cyclosporine-A uptake in human erythrocytes. Eur. J. Clin. Pharmacol. 46, 417-419.
20. 20. Reisdorff J. A., Trevino L. D., Velasquez I. V. D. and Jackson M. (1992) The effect of cyclosporin concentration on the efficiency of in vitro technetium-99m radiolabeling of red blood cells. J. Nucl. Med. Technol. 20, 147-150.
21. 21. Srivastava S. C. and Chervu L. R. (1984) Radionuclide labeled red blood cells, current status and future prospects. Semin. Nucl. Med. 14, 68-82.
22. 22. Starzl T. E., Weil R., Iwatsuki J. T., Klintmaln G. B. G., Schroter G. P. J., Koep L. J., Iwaki Y., Terasaki P. and Porter K. (1980) The use of cyclosporin-A and prednisone in cadaver kidney transplantation. Surg. Gynecol. Obstet. 151, 17-26.
23. 23. Thakur M. L., Coleman R. E. and Welch M. J. (1977) Indium-111-labeled leukocytes for the localization of abscesses: Preparation, analysis, tissue distribution and comparison with gallium-67 citrate in dogs. J. Lab. Clin. Med. 89, 217-228.
24. 24. Thakur M. L., Segal A. W., Louis L., Welch M. J., Hopkins J. and Peters T. J. (1977) Indium-111 labeled cellular blood components: Mechanism of labeling and intracellular localization in human neutrophils. J. Nucl. Med. 18, 1020-1024.
25. 25. Von Graffenried B. and Harrison W. B. (1985) Renal function in patients with autoimmune diseases treated with cyclosporine. Transplant Proc. 17 (Suppl. 1), 215-231.
26. 26. White R. J. and Garrison W. M. (1994) Cyclosporine. In: Basic Clinical Pharma-cokinetics, pp. 73-80. Applied Therapeutics, Inc., Vancouver, WA.